Biofortuna Expands Dried PCR Reagents Business Citing Increased Demand from Dx Clients | GenomeWeb

NEW YORK (GenomeWeb) — Citing increased demand from companies outsourcing freeze-drying of diagnostic kits, molecular diagnostics firm Biofortuna has expanded its PCR reagent lyophilization production service.

After receiving a £1.3 million ($2.0 million) investment last August to expand its custom service and manufacturing business, the company has now doubled its production capacity and enhanced infrastructure at its Wirral, UK, headquarters.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.